Atherosclerosis has been recognized as a chronic inflammatory disease, which can harden the vessel wall and narrow the arteries. MicroRNAs exhibit crucial roles in various diseases including atherosclerosis. However, so far, the role of miR‐328 in atherosclerosis remains barely explored. Therefore, our study concentrated on the potential role of miR‐328 in vascular endothelial cell injury during atherosclerosis. In our current study, we observed that oxidized low‐density lipoprotein (ox‐LDL)‐induced human umbilical vein endothelial cells (HUVECs) apoptosis and inhibited cell viability dose‐dependently and time‐dependently. In addition, indicated dosage of ox‐LDL obviously triggered HUVECs inflammation and oxidative stress process. Then, it was found that miR‐328 in HUVECs was reduced by ox‐LDL. HUVECs apoptosis was greatly repressed and cell survival was significantly upregulated by overexpression of miR‐328. Furthermore, mimics of miR‐328 rescued cell inflammation and oxidative stress process induced by ox‐LDL. Oppositely, inhibitors of miR‐328 strongly promoted ox‐LDL‐induced endothelial cells injury in HUVECs. By using bioinformatics analysis, high‐mobility group box‐1 (HMGB1) was predicted as a downstream target of miR‐328. HMGB1 has been reported to be involved in atherosclerosis development. The correlation between miR‐328 and HMGB1 was validated in our current study. Taken these together, it was implied that miR‐328 ameliorated ox‐LDL‐induced endothelial cells injury through targeting HMGB1 in atherosclerosis.